tiprankstipranks
Trending News
More News >

Evogene Shareholders Approve Key Proposal in Special Meeting

Story Highlights
Evogene Shareholders Approve Key Proposal in Special Meeting

Confident Investing Starts Here:

The latest announcement is out from Evogene ( (EVGN) ).

On February 12, 2025, Evogene Ltd. announced that its shareholders approved a proposal at a special general meeting, following an adjournment from its original date. This decision aligns with the Israeli Companies Law and the company’s articles of association, marking a significant step in the company’s governance processes.

More about Evogene

Evogene Ltd. is a biotechnology company based in Israel, focusing on the development of products for life science markets, including agriculture, human health, and industrial applications.

YTD Price Performance: -23.40%

Average Trading Volume: 58,991

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $8.37M

For a thorough assessment of EVGN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App